Jounce Therapeutics is based in Cambridge, Massachusetts. It has raised $103M in total funding. Latest round: Series B.
Jounce Therapeutics is based in Cambridge, Massachusetts. Jounce Therapeutics has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2019. The round record for Jounce Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Third Rock Ventures, Redmile Group, Wellington Management Company, Foresite Capital Management, Celgene Corp, Nextech Invest and 1 others. 7 distinct backers are named across the disclosed rounds.
We update the Jounce Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026